ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV

This adverse event was reported 28 times

ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEXTROSE AND SODIUM CHLORIDE 1 0.0060
1 FLUDEOXYGLUCOSE F-18 1 0.0035
2 CHLORAMBUCIL 2 0.0005
3 SUCCINYLCHOLINE CHLORIDE 1 0.0004
4 RASBURICASE 1 0.0004
5 DEXMEDETOMIDINE HYDROCHLORIDE 1 0.0003
6 HYDROCORTISONE SODIUM SUCCINATE 1 0.0003
7 VASOPRESSIN 1 0.0002
8 ALBUMIN HUMAN 1 0.0002
9 KETAMINE HYDROCHLORIDE 1 0.0002
See all drugs enriched for association with ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV

ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Radioactive Diagnostic Agent [EPC] 1 0.0003
1 Cannabinoid [EPC] 1 0.0001
2 CD30-directed Immunoconjugate [EPC] 1 0.0001
3 Aluminum Complex [EPC] 1 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 18 0.0000
5 Radiographic Contrast Agent [EPC] 1 0.0000
6 Provitamin D2 Compound [EPC] 1 0.0000
7 Topoisomerase Inhibitor [EPC] 2 0.0000
8 General Anesthetic [EPC] 1 0.0000
9 Folate Analog [EPC] 1 0.0000
See all drug classes enriched for association with ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV